News

MacKay Shields Welcomes Alison Micucci as New CEO

MacKay Shields Welcomes Alison Micucci as New CEO

MacKay Shields Announces Appointment of Alison Micucci

MacKay Shields, an $151 billion asset management firm, is thrilled to announce that Alison Micucci will take on the role of CEO. Effective from the start of 2025, she will lead the company as it seeks to expand its services and capabilities in the asset management sector.

Alison Micucci: A Leader with Vast Experience

With a wealth of knowledge and experience in the asset management field, Alison Micucci represents a strong choice for MacKay Shields. She will succeed under the leadership of Naïm Abou-Jaoudé, who also serves as CEO of New York Life Investment Management and Chairman of MacKay Shields.

Excitement Surrounding the New Appointment

Abou-Jaoudé expressed his enthusiasm for Micucci’s leadership, stating, "I am excited for Alison to lead MacKay’s next stage of growth. She brings invaluable insights and expertise that will benefit both our clients and the firm’s culture." With her at the helm, the firm is well-positioned to seize upcoming growth opportunities.

Micucci's Proven Track Record

Alison’s experience with New York Life, where she started in 2002, includes various senior leadership roles. These positions include overseeing Institutional Annuities and serving as Chief Administrative Officer for New York Life Investments, along with spearheading business planning and strategy initiatives.

Strategic Contributions to New York Life

During her time at New York Life, Micucci was instrumental in launching New York Life Ventures and driving transformation projects aimed at enhancing client operations. Additionally, she played a key role in the international asset management strategy of New York Life Investments. Most recently, she has led New York Life Direct, the leading provider in direct-to-consumer life insurance.

Looking Ahead with Confidence

Micucci expressed her gratitude and excitement regarding her new role at MacKay Shields. She remarked, "I’m honored to lead this exciting next chapter for MacKay Shields. The firm is a leader in specialty fixed income and has a history of using research-driven investment processes to create value for clients. I look forward to collaborating with everyone at MacKay to continue delivering exceptional investment performance and long-term value."

About MacKay Shields

MacKay Shields LLC is a respected global asset management firm affiliated with New York Life Investments, boasting $151 billion in assets under management as of September 30, 2024. MacKay specializes in fixed income strategies tailored for high-net-worth individuals and institutional clientele. The firm’s approach incorporates separately managed accounts and collective investment vehicles such as private funds and mutual funds.

Focused Expertise Across Various Markets

With its specialist knowledge across global fixed income markets—including municipal bonds, high yield bonds, and structured credit—MacKay Shields provides clients with expertise that informs investment decisions. This commitment ensures that investors have direct access to senior investment professionals, bolstering transparency and service quality.

Corporate Overview and Future Directions

MacKay Shields is dedicated to delivering investment excellence and enhancing client relationships. With an expanding office presence across major cities like New York, London, and Dublin, the firm is poised to strengthen its global footprint in the asset management landscape.

Frequently Asked Questions

Who has been appointed as the new CEO of MacKay Shields?

Alison Micucci has been appointed as the new CEO of MacKay Shields, effective January 1, 2025.

What is MacKay Shields' primary focus in asset management?

MacKay Shields specializes in fixed income strategies, catering to both high-net-worth individuals and institutional clients.

What positions has Alison Micucci held before her appointment?

Prior to her CEO appointment, Micucci has held various senior leadership roles within New York Life, including overseeing Institutional Annuities and leading New York Life Direct.

How does MacKay Shields maintain its client relationships?

MacKay Shields ensures investors have direct access to senior investment professionals, enhancing communication and service delivery.

What assets under management does MacKay Shields currently oversee?

As of September 30, 2024, MacKay Shields manages approximately $151 billion in assets.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 38

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 38

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 45

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 47

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 44

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 35

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading

Top 5 Most Recently Viewed Articles

Impact of Tariff Loophole Elimination on Global Commerce

Updated Category News Views 406

Understanding the Elimination of De Minimis Tariffs The United States is set to amend its tariff regulations, specifically abolishing the "de minimis" exemption that previously allowed low-value imports to enter duty-free. This change aims to enhance oversight on imports and curtail tariff evasion, sparking significant shifts within the global commerce landscape. What the...

Continue Reading
Coherent Showcases Cutting-Edge Innovations at Upcoming Eco-C 2024

Updated Category News Views 157

Coherent's Exciting Innovations at ECOC 2024 Coherent Corp. (NYSE: COHR), recognized as a leader in optical communications components and subsystems, is gearing up to showcase its groundbreaking innovations at the upcoming ECOC 2024 exhibition. Scheduled to take place at Messe Frankfurt, this year’s event will highlight advancements that aim to enhance optical...

Continue Reading
Bekaert Expands Share Buyback Program and Provides Updates

Updated Category News Views 262

Bekaert Share Buyback Program Overview Recently, Bekaert has introduced an exciting expansion regarding its share buyback program. This initiative serves a crucial purpose: to enhance shareholder value through the repurchase of its own shares. The latest tranche of this program allows for a significant capital return of up to €25 million. By canceling the shares it...

Continue Reading
DTE Energy's Hallelujah for Heat Concert Returns to Lift Spirits

Updated Category News Views 252

DTE Energy's Hallelujah for Heat Concert Returns DTE Energy is excited to announce the return of its highly anticipated event, Hallelujah for Heat. This vibrant concert is set to take place at a local venue soon, bringing together community members in support of families facing challenges during the cold season. A Celebration of Community and Compassion This year's...

Continue Reading
Legal Action Intensifies Following Lewiston Mass Shooting Events

Updated Category News Views 244

Attorneys for Survivors Amend Lawsuit Against U.S. The aftermath of a tragic mass shooting can leave deep scars on a community. In Lewiston, a critical legal battle is unfolding as attorneys representing survivors and families of victims have amended their lawsuit against the U.S. government. This legal action follows clear evidence pointing to the Department of Defense's...

Continue Reading